Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose tenecteplase versus standard of care for minor ischemic stroke with acute symptomatic occlusion
2015-005469-22Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in ischemic stroke comparing Low-dose tenecteplase with Standard of care (2 arms). Started Aug 2016; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2015-005469-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005469-22.